FindTrial
Sign In

A randomized controlled trial for perioperative administration of tolvaptan in improving postoperative recovery in patients with cirrhosis

A randomized controlled trial for perioperative administration of tolvaptan in improving postoperative recovery in patients with cirrhosis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017639
Enrollment
Unknown
Registered
2018-08-07
Start date
2018-10-01
Completion date
Unknown
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis

Interventions

Group 1:Tolvaptan + Furosemide
Group 2:Furosemide

Sponsors

Shanghai Public Health Clinical Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 18-80-year-old patients with cirrhosis who underwent surgery were eligible for surgery and had no clear surgical contraindications.

Exclusion criteria

Exclusion criteria: With surgical contraindications

Design outcomes

Primary

MeasureTime frame
Ascites content;—

Countries

China

Contacts

Public ContactHuang Yangqing

Shanghai Public Health Clinical Center

eric_huangyq@163.com+86 18930386621

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026